arrow
S

Stephen Bagley

University of Pennsylvania
H指数:32
被引数:4,682

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2 study of niraparib concomitant with Tumor Treating Fields in patients with recurrent grade 4 glioma

尼拉帕利与肿瘤治疗电场联合治疗复发性4级胶质瘤的2期研究

2026-04-200
OA
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
Immune remodeling in CSF and tumor predicts response to CAR T therapy in glioblastoma

脑脊液和肿瘤中的免疫重塑预测胶质母细胞瘤对CAR T疗法的反应

2025-11-010
OAAI
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
Self-supervised multimodal learning for survival prediction in glioblastoma: a multicenter study from the ReSPOND consortium

用于胶质母细胞瘤生存预测的自监督多模态学习:来自ReSPOND联盟的多中心研究

2025-11-010
PRE
Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative

颅内转移瘤:神经肿瘤学会和临床肿瘤学会协作的呼吁与共识

2025-10-060
OAAI
A PHASE 2 STUDY OF PEMIGATINIB FOR PRE-TREATED GLIOBLASTOMA OR OTHER GLIOMAS WITH ACTIVATING FGFR1-3 ALTERATIONS: FINAL RESULTS FROM FIGHT-209

一项关于佩米加替尼治疗经治胶质母细胞瘤或其他携带激活性FGFR1-3变异的胶质瘤的II期研究:FIGHT-209的最终结果

2025-10-010
OAAI
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

脑肿瘤液体活检方法中的前分析变量和检测物:RANO Group和Brain Liquid Biopsy Consortium的综述与建议

2025-08-010
PRE
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, et al. 静脉内双价CAR T细胞靶向EGFR和IL-13Rα2治疗复发性胶质母细胞瘤:一项1期临床试验。Nat Med. (2025). doi: 10.1038/s41591-025-03745-0

2025-06-010
PRE
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic drivers
2025-03-010
OA
AI-GUIDED PERSONALIZED PRECISION RADIATION THERAPY WITH TARGETED DOSE ESCALATION FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MATCHED-CONTROL STUDY
2024-11-110
PRE
SUBTYPING GLIOBLASTOMA FROM JOINT CLUSTERING OF IMAGING AND GENOMIC DATA
2024-11-110
PRE
PATIENT-DERIVED GLIOBLASTOMA ORGANOIDS AS REAL-TIME AVATARS FOR ASSESSING RESPONSES TO CLINICAL CAR-T CELL THERAPY

患者来源的胶质母细胞瘤类器官作为实时化身,用于评估对临床car-t细胞治疗的反应

2024-11-110
PRE